Fidelity International
ABCL icon

Fidelity International’s AbCellera Biologics ABCL Stock Holding History

Fidelity International’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,061
Closed -$70.5K – 906
2024
Q4 		$70.5K Sell
24,061
-99,818
-81% -$278K ﹤0.01% 865
2024
Q3 		$322K Buy
123,879
+3,906
+3% +$10.8K ﹤0.01% 814
2024
Q2 		$355K Buy
119,973
+54,893
+84% +$208K ﹤0.01% 778
2024
Q1 		$295K Sell
65,080
-1,810,792
-97% -$9.24M ﹤0.01% 786
2023
Q4 		$10.7M Buy
+1,875,872
New +$8.69M 0.01% 497
2023
Q2 		– Sell
-19,638
Closed -$148K – 804
2023
Q1 		$148K Sell
19,638
-1,518
-7% -$13.8K ﹤0.01% 764
2022
Q4 		$214K Buy
21,156
+1,718
+9% +$19.8K ﹤0.01% 767
2022
Q3 		$192K Buy
+19,438
New +$213K ﹤0.01% 771

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return